Reaction
Malignant Neoplasm Oligoprogression reporting signals
As of the last recalculation, Malignant Neoplasm Oligoprogression appears in 173 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is PEMETREXED (PRR 141.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pemetrexed | 22 | 141.3 | 141.4 |
| Pembrolizumab | 66 | 121.4 | 121.5 |
| Pemetrexed Disodium | 25 | 92.1 | 92.2 |
| Osimertinib | 17 | 70.7 | 70.7 |
| Abiraterone | 5 | 45.5 | 45.5 |
| Ipilimumab | 14 | 42.4 | 42.4 |
| Olaparib | 7 | 41.9 | 41.9 |